CTXR

Conviction 0HealthcareScan · Thu, Jun 25, 2026

CTXR$0.5528-3.02%

ResistanceSupportVol 14

Vol MA14 269.5K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Citius Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.citiuspharma.com ↗

Price0.5528

Change-3.02%

Gap-0.79%

Rel volume0.51×

Avg volume334.85K

Avg $ vol197.38K

SMA 200.5753

SMA 500.6558

SMA 2000.9422

Price vs 50-15.71%

Price vs 200-41.33%

MA stackbearish

50/200 cross—

Supertrenddown · 0.6926

RSI (14)42

MACD hist0.00

MACD crossbull · 3d

Stoch %K / %D25 / 34

ADX (14)20

+DI / −DI16 / 24

RSI divergence—

MACD divergence—

ATR %+8.80%

ADR %7.56%

52w high2.21

52w low0.5270

From 52w high-74.99%

Above 52w low+4.90%

New 52w highNo

SqueezeOn · 1d

Bollinger width24.40%

%B0.34

Donchian pos11.86%

Donchian high0.7200

Donchian low0.5303

AVWAP (52w high)1.12

vs AVWAP high-50.76%

AVWAP (52w low)0.5926

vs AVWAP low-6.71%

OBV trendDown

Chaikin MF (20)-0.53

Today vs 20d0.51×

Avg vol (14d)269.5K

Avg vol (20d)334.85K

Avg $ vol (20d)197.38K

Market cap15.18M

RS 3m (vs SPY)-31.98%

RS 6m (vs SPY)-54.46%

RS line new highNo

Trend template0/8

Technical rank9.9

1 week+2.37%

1 month-20.69%

3 months-23.22%

6 months-47.35%

1 year-57.15%

YTD-34.81%

P/E-0.47

P/B0.25

P/S—

P/FCF-0.57

EPS-3.38

Div yield—

ROE-52.88%

ROA-24.55%

Debt/Eq—

Current0.58

EV/EBITDA-0.27

Gross margin—

Net margin—

Rev growth—

EPS growth3.26%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value10.59M

Revenue1.67M

Net income-11.51M

Gross profit1.34M

Free cash flow-26.56M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees23

ListedTue, Oct 18, 2011

Free float21.22M

Float %94.9%

Short interest4.95M

Days to cover5.5d

Short volume11.3%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank9.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7423

Support0.5031

Days since event—

Candle confirm—

News sentiment—

Financials as of Mon, Mar 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in CTXR

All disclosures →

No recent disclosed trades by Congress in CTXR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CTXR

No recent insider (Form 4) filings in CTXR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CTXR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.